| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 04/12/2012 | US20120088782 Lpa receptor antagonist |
| 04/12/2012 | US20120088780 SUBSTITUTED [1,2,4]TRIAZOLO[1,5-a]PYRIMIDINES AND THEIR USE AS POTASSIUM CHANNEL MODULATORS |
| 04/12/2012 | US20120088778 Azole derivatives and fused bicyclic azole derivatives as therapeutic agents |
| 04/12/2012 | US20120088770 Alpha helix mimetics and methods relating thereto |
| 04/12/2012 | US20120088769 Salts of arylsulfonamide ccr3 antagonists |
| 04/12/2012 | US20120088768 Pinane-substituted pyrimidinediamine derivatives useful as axl inhibitors |
| 04/12/2012 | US20120088767 Benzimidazole derivatives as pi3 kinase inhibitors |
| 04/12/2012 | US20120088766 Fused heterocyclic compounds and their uses |
| 04/12/2012 | US20120088765 Purine derivative and antitumor agent using same |
| 04/12/2012 | US20120088764 Phosphoinositide 3-kinase inhibitors with a zinc binding moiety |
| 04/12/2012 | US20120088762 Compounds for enzyme inhibition |
| 04/12/2012 | US20120088757 Novel 1,4-benzodiazepine-2,5-diones with therapeutic properties |
| 04/12/2012 | US20120088756 Methods for Regulating Neurotransmitter Systems by Inducing Counteradaptations |
| 04/12/2012 | US20120088754 Sulfonyl-derivatives as novel inhibitors of histone deacetylase |
| 04/12/2012 | US20120088753 Pyrrolopyrimidines and used as kinase inhibitors |
| 04/12/2012 | US20120088752 Hedgehog pathway antagonists and therapeutic applications thereof |
| 04/12/2012 | US20120088749 S1P Receptor Modulating Compounds and Use Thereof |
| 04/12/2012 | US20120088746 Amide derivatives as ion-channel ligands and pharmaceutical compositions and methods of using the same |
| 04/12/2012 | US20120088741 Aryl-substituted heterocyclic urea modulators of fatty acid amide hydrolase |
| 04/12/2012 | US20120088723 Selective ep4 receptor agonistic substance for treatment of cancer |
| 04/12/2012 | US20120088720 Inhibitors of protein tyrosine phosphatases |
| 04/12/2012 | US20120088713 Tnf inhibitor formulation for use in implantable infusion devices |
| 04/12/2012 | US20120088664 Antifungal 1,2,4-triazolyl derivatives having a 5-sulfur subtituent |
| 04/12/2012 | US20120088663 Triazole Compounds Carrying a Sulfur Substituent |
| 04/12/2012 | US20120088660 Antifungal 1,2,4-triazolyl Derivatives |
| 04/12/2012 | US20120088264 Methods for determining efficacy of chemotherapeutic agents |
| 04/12/2012 | US20120088255 Her-2 binding antagonists |
| 04/12/2012 | US20120087989 Use of gelled prp (platelet gel) for volumetric breast reconstruction |
| 04/12/2012 | US20120087988 Methods and compositions for treating respiratory conditions using platelet enriched plasma |
| 04/12/2012 | US20120087984 Stabilization of chemical compounds using nanoparticulate formulations |
| 04/12/2012 | US20120087976 Adjuvant compositions comprising a non-ionic isotonicity agent |
| 04/12/2012 | US20120087975 Method of Producing A Cationic Liposomal Preparation Comprising A Lipophilic Compound |
| 04/12/2012 | US20120087959 Nanodispersion of a drug and process for its preparation |
| 04/12/2012 | US20120087955 Nanoparticulate megestrol formulations |
| 04/12/2012 | US20120087947 Use of 2,5-dihydroxybenzene derivatives for treating dermatitis |
| 04/12/2012 | US20120087931 Therapeutic and diagnostic anti-hsp70 antibodies |
| 04/12/2012 | US20120087927 Antibody containing igg2 having amino acid mutation introduced therein |
| 04/12/2012 | US20120087925 Method for the treatment of inflammatory disorders |
| 04/12/2012 | US20120087922 Dr5 antibodies and uses thereof |
| 04/12/2012 | US20120087921 Novel chemokine binding polypeptides capable of inhibiting the course of autoimmunity, inflammation and cancer |
| 04/12/2012 | US20120087919 Method for treating diabetes |
| 04/12/2012 | US20120087918 Methods and compositions for inhibiting the growth of hematopoietic malignant cells |
| 04/12/2012 | US20120087917 Lox and loxl2 inhibitors and uses thereof |
| 04/12/2012 | US20120087916 Anti-icam-1 antibody, uses and methods |
| 04/12/2012 | US20120087915 Use of inhibitors of bruton's tyrosine kinase (btk) |
| 04/12/2012 | US20120087914 Inhibition of trim62 activity reduces cancer cell proliferation |
| 04/12/2012 | US20120087913 Induction of tumor hypoxia for cancer therapy |
| 04/12/2012 | US20120087910 Sparc angiogenic domain and methods of use |
| 04/12/2012 | US20120087904 Use Of 2,5-Dihydroxybenzene Compounds And Derivatives For The Treatment Of Skin Cancer |
| 04/12/2012 | US20120087901 Engineered Mesenchymal Stem Cells and Methods of Using Same to Treat Tumors |
| 04/12/2012 | US20120087896 Hydroxylated 1,2,4-oxadiazole benzoic acid compounds, compositions thereof and their use in bioassays |
| 04/12/2012 | US20120087894 Producer cells for replication competent retroviral vectors |
| 04/12/2012 | US20120087892 Identification of dsg-3 as a biomarker for the detection of metastasis in lymph nodes |
| 04/12/2012 | US20120087891 Reversible Gel-forming Compositions for Controlled Delivery of Bioactive Substances |
| 04/12/2012 | US20120087868 Nanoparticle-loaded cells |
| 04/12/2012 | US20120087859 Nanocarrier having enhanced skin permeability, cellular uptake and tumour delivery properties |
| 04/12/2012 | US20120087857 Gadolinium expressed lipid nanoparticles for magnetic resonance imaging |
| 04/12/2012 | DE102010042338A1 Zusammensetzung zur Behandlung von Krebs mit kontrollierter Freisetzung des Wirkstoffes A composition for treatment of cancer with controlled release of the active ingredient |
| 04/12/2012 | CA2814084A1 Inhibitors of polo-like kinase |
| 04/12/2012 | CA2814024A1 Moesin modulators and uses thereof |
| 04/12/2012 | CA2813814A1 Tumor specific antibodies and uses therefor |
| 04/12/2012 | CA2813738A1 Mutant smoothened and methods of using the same |
| 04/12/2012 | CA2813607A1 Substituted pyridazine carboxamide compounds |
| 04/12/2012 | CA2813580A1 Substituted pyridazine carboxamide compounds as kinase inhibitor compounds |
| 04/12/2012 | CA2813557A1 Method for activating helper t cell |
| 04/12/2012 | CA2813329A1 Crystalline (r)-(e)-2-(4-(2-(5-(1-(3,5-dichloropyridin-4-yl)ethoxy)-1h-indazol-3-yl)vinyl)-1h-pyrazol-1-yl)ethanol |
| 04/12/2012 | CA2813153A1 4-(methylaminophenoxy) pyrdin-3-yl-benzamide derivatives for treating cancer |
| 04/12/2012 | CA2813080A1 Detection of fusobacterium in a gastrointestinal sample to diagnose gastrointestinal cancer |
| 04/12/2012 | CA2812926A1 Picropodophyllin monohydrate or polymorph a in cancer therapy |
| 04/12/2012 | CA2812921A1 Picropodophyllin polymorphs b or c for use in cancer therapy |
| 04/12/2012 | CA2812786A1 Pharmaceutical combinations |
| 04/12/2012 | CA2812608A1 Benzimidazole derivatives as pi3 kinase inhibitors |
| 04/12/2012 | CA2805387A1 Environmentally sensitive compositions |
| 04/11/2012 | EP2439206A1 Thiophene-carboxamides useful as inhibitors of protein kinases |
| 04/11/2012 | EP2439204A1 Heterocyclic compound and hematopoietic stem cell amplifier |
| 04/11/2012 | EP2439196A1 Diarylthiohydantoin compounds for use in a method for the treatment of a hyperproliferative disorder |
| 04/11/2012 | EP2439195A1 Naphthalene carboxamide derivatives as inhibitors of protein kinase and histone deacetylase, preparation methods and uses thereof |
| 04/11/2012 | EP2439194A1 Phenyl diamides and a pharmaceutical preparation comprising phenyl diamides |
| 04/11/2012 | EP2438916A1 Neurite elongation agent, memory-improving agent and anti-alzheimer agent comprising 4'-demethylnobiletin or 4'-demethyltangeretin as active ingredient, and process for production of the compound |
| 04/11/2012 | EP2438914A1 Pharmaceutical composition comprising Z-butylidenephthalide for treating brain cancer or reducing temozolomide-resistance of brain cancer cells and use |
| 04/11/2012 | EP2438191A1 Lysine-specific demethylase 1 (lsd1) is a biomarker for breast cancer |
| 04/11/2012 | EP2438169A1 Nucleic acid modulators of glycoprotein vi |
| 04/11/2012 | EP2438167A1 Therapeutic and diagnostic molecules |
| 04/11/2012 | EP2438084A2 Antibodies against human ccn1 and uses thereof |
| 04/11/2012 | EP2438066A2 PREPARATION AND USES OF 1,2,4-TRIAZOLO [1,5a]PYRIDINE DERIVATIVES |
| 04/11/2012 | EP2438064A1 1H-IMIDAZO[4,5-c]QUINOLINONE DERIVATIVES |
| 04/11/2012 | EP2438063A1 1h-imidazo[4,5-c]quinolinone compounds, useful for the treatment of proliferative diseases |
| 04/11/2012 | EP2438056A2 Amino pyrimidine anticancer compounds |
| 04/11/2012 | EP2438052A1 Azole derivatives as wtn pathway inhibitors |
| 04/11/2012 | EP2438048A2 Polycyclic antagonists of lysophosphatidic acid receptors |
| 04/11/2012 | EP2437788A1 Proteins modified with (amino)-monosaccharide-biotin adduct |
| 04/11/2012 | EP2437775A1 Fgf-21 for treating cancers |
| 04/11/2012 | EP2437760A1 Oncolytic virotherapy for prevention of tumor recurrence |
| 04/11/2012 | EP2437759A1 Method for cancer therapy based on co-administration of a parvovirus and a cytokine |
| 04/11/2012 | EP2437749A2 Interlaced method for treating cancer or a precancerous condition |
| 04/11/2012 | EP2437745A1 Treatment of mammalian disorders mediated by alpha-carbonic anhydrase isoforms |
| 04/11/2012 | EP2437738A2 Methods and compositions for the treatment of cancer |
| 04/11/2012 | EP2310383B8 Derivatives of 2-oxo-alkyl-1-piperazin-2-one, preparation method thereof and therapeutic use of same |
| 04/11/2012 | EP2131845B1 5-(2,4-dihydroxy-5-isopropyl-phenyl)-4-(4-morpholin-4-ylmethyl-phenyl)-isoxazole-3-carboxylic acid ethylamide mesylate, hydrates and polymorphs thereof, and formulations comprising these forms |
| 04/11/2012 | EP2119718B1 Macrocyclic compound |